Targeted therapy in eosinophilic chronic obstructive pulmonary disease.

Fieldes, Mathieu; Bourguignon, Chloé; Assou, Said; Nasri, Amel; Fort, Aurélie; Vachier, Isabelle; De Vos, John; Ahmed, Engi; Bourdin, Arnaud

Fieldes, Mathieu; Bourguignon, Chloé; Assou, Said; Nasri, Amel; Fort, Aurélie; Vachier, Isabelle; De Vos, John; Ahmed, Engi; Bourdin, Arnaud.

Afiliación

Fieldes M; IRMB, INSERM, Montpellier University Hospital, Montpellier, France.
Bourguignon C; IRMB, INSERM, Montpellier University Hospital, Montpellier, France.
Assou S; IRMB, INSERM, Montpellier University Hospital, Montpellier, France.
Nasri A; IRMB, INSERM, Montpellier University Hospital, Montpellier, France.
Fort A; Dept of Respiratory Diseases, Montpellier University Hospital, INSERM, Montpellier, France.
Vachier I; PhyMedExp, University of Montpellier, INSERM U1046, Montpellier, France.
De Vos J; Dept of Respiratory Diseases, Montpellier University Hospital, INSERM, Montpellier, France.
Ahmed E; IRMB, INSERM, Montpellier University Hospital, Montpellier, France.
Bourdin A; Dept of Cell and Tissue Engineering, Montpellier University Hospital, Montpellier, France.

ERJ Open Res ; 7(2)2021 Apr.

Article en En | MEDLINE | ID: mdl-33855061

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_asthma / 6_chronic_obstructive_pulmonary_disease Tipo de estudio: Risk_factors_studies Idioma: En Revista: ERJ Open Res Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google